SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-007537
Filing Date
2023-03-22
Accepted
2023-03-22 16:15:43
Documents
69
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K mbrx20221231_10k.htm   iXBRL 10-K 1801280
2 EXHIBIT 10.27 ex_491248.htm EX-10.27 175874
3 EXHIBIT 21 ex_448110.htm EX-21 1753
4 EXHIBIT 23.1 ex_448111.htm EX-23.1 2583
5 EXHIBIT 31.1 ex_448112.htm EX-31.1 12111
6 EXHIBIT 31.2 ex_448113.htm EX-31.2 12114
7 EXHIBIT 32.1 ex_448114.htm EX-32.1 5464
8 EXHIBIT 32.2 ex_448115.htm EX-32.2 5468
  Complete submission text file 0001437749-23-007537.txt   7582694

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20221231.xsd EX-101.SCH 66182
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20221231_cal.xml EX-101.CAL 54661
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20221231_def.xml EX-101.DEF 387248
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20221231_lab.xml EX-101.LAB 401260
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20221231_pre.xml EX-101.PRE 424308
63 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20221231_10k_htm.xml XML 1153253
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37758 | Film No.: 23753116
SIC: 2834 Pharmaceutical Preparations